Clinical relevance of circulating anti-ENA and anti-dsDNA secreting cells from SLE patients and their dependence on STAT-3 activation-Reference-Cited by-同舟云学术

Clinical relevance of circulating anti-ENA and anti-dsDNA secreting cells from SLE patients and their dependence on STAT-3 activation

Published:2017-05-23 Issue:7 Volume:47 Page:1211-1219
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

de la Varga Martínez Raquel¹²,Rodríguez-Bayona Beatriz³,Añez Gustavo A.⁴,Medina Varo Fermín⁴,Pérez Venegas José J.⁵,Brieva José A.¹,Rodríguez Carmen²^ORCID

Affiliation:

1. Unidad de Investigación; Hospital Universitario Puerta del Mar (HUPM); Cádiz

2. Servicio de Inmunología; UGC de Hematología e Inmunología; HUPM; Cádiz

3. Área de Inmunología; UGC de Análisis Clínicos; Complejo Hospitalario Universitario de Huelva; Hospital Juan Ramón Jiménez Huelva

4. Sección de Reumatología; UGC de Cirugía Ortopédica; Traumatología y Reumatología; HUPM; Cádiz

5. UGC de Reumatología; Hospital de Jerez de la Frontera; Cádiz

Funder

Consejería de Salud. Junta de Andalucía. Spain

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Reference44 articles.

1. Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity;Lipsky;Nat. Immunol.,2001

2. Mechanisms of autoantibody production in systemic lupus erythematosus;Han;Front. Immunol.,2015

3. Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus;Tipton;Nat. Immunol.,2015

4. Invariant natural killer T cells in lupus patients promote IgG and IgG autoantibody production;Shen;Eur. J. Immunol.,2015

5. Antibodies to DNA;Hahn;N. Engl. J. Med.,1998

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dysregulated CXCL12 expression in osteoblasts promotes B-lymphocytes preferentially homing to the bone marrow in MRL/lpr mice;Autoimmunity;2024-02-25

2. Outlook of the jakinibs in systemic lupus erythematous after baricitinib failed;International Journal of Rheumatic Diseases;2024-02

3. The role of Interleukin-21 in autoimmune Diseases: Mechanisms, therapeutic Implications, and future directions;Cytokine;2024-01

4. B cell-targeted polylactic acid nanoparticles as platform for encapsulating jakinibs: potential therapeutic strategy for systemic lupus erythematosus;Nanomedicine;2023-11

5. Janus kinase inhibitors in systemic lupus erythematosus: implications for tyrosine kinase 2 inhibition;Frontiers in Medicine;2023-06-29